137 related articles for article (PubMed ID: 14966828)
1. Factors influencing central line infections in children with acute lymphoblastic leukemia: results of a single institutional study.
Abbas AA; Fryer CJ; Paltiel C; Chedid F; Felimban SK; Yousef AA; Khattab TM
Pediatr Blood Cancer; 2004 Apr; 42(4):325-31. PubMed ID: 14966828
[TBL] [Abstract][Full Text] [Related]
2. Placing of tunneled central venous catheters prior to induction chemotherapy in children with acute lymphoblastic leukemia.
Handrup MM; Møller JK; Frydenberg M; Schrøder H
Pediatr Blood Cancer; 2010 Aug; 55(2):309-13. PubMed ID: 20582964
[TBL] [Abstract][Full Text] [Related]
3. Central venous lines in children with lesser risk acute lymphoblastic leukemia: optimal type and timing of placement.
McLean TW; Fisher CJ; Snively BM; Chauvenet AR
J Clin Oncol; 2005 May; 23(13):3024-9. PubMed ID: 15860859
[TBL] [Abstract][Full Text] [Related]
4. The safety of central line placement prior to treatment of pediatric acute lymphoblastic leukemia.
Carr E; Jayabose S; Stringel G; Slim M; Ozkaynak MF; Tugal O; Sandoval C
Pediatr Blood Cancer; 2006 Dec; 47(7):886-8. PubMed ID: 16200633
[TBL] [Abstract][Full Text] [Related]
5. Totally implantable central venous access devices in children with hemato-oncologic malignancies: evaluation of complications and comparison of incidence of febrile episodes with similar patients without central venous access devices.
Sarper N; Zengin E; Corapçioglu F; Tugay M
Pediatr Hematol Oncol; 2006 Sep; 23(6):459-70. PubMed ID: 16849276
[TBL] [Abstract][Full Text] [Related]
6. Infections during induction therapy of childhood acute lymphoblastic leukemia--no association to mannose-binding lectin deficiency.
Lausen B; Schmiegelow K; Andreassen B; Madsen HO; Garred P
Eur J Haematol; 2006 Jun; 76(6):481-7. PubMed ID: 16494622
[TBL] [Abstract][Full Text] [Related]
7. [Central venous totally implantable access for high dose chemotherapy in children].
Conter C; Carausu L; Martin E; Rubie H; Castex MP; Marec-Berard P
Arch Pediatr; 2006 Mar; 13(3):256-61. PubMed ID: 16469486
[TBL] [Abstract][Full Text] [Related]
8. Incidence of skeletal complications during treatment of childhood acute lymphoblastic leukemia: comparison of fracture risk with the General Practice Research Database.
Högler W; Wehl G; van Staa T; Meister B; Klein-Franke A; Kropshofer G
Pediatr Blood Cancer; 2007 Jan; 48(1):21-7. PubMed ID: 16317756
[TBL] [Abstract][Full Text] [Related]
9. Severe neutropenia at time of port insertion is not a risk factor for catheter-associated infections in children with acute lymphoblastic leukemia.
Junqueira BL; Connolly B; Abla O; Tomlinson G; Amaral JG
Cancer; 2010 Sep; 116(18):4368-75. PubMed ID: 20564151
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for infection-related outcomes during induction therapy for childhood acute lymphoblastic leukemia.
Afzal S; Ethier MC; Dupuis LL; Tang L; Punnett AS; Richardson SE; Allen U; Abla O; Sung L
Pediatr Infect Dis J; 2009 Dec; 28(12):1064-8. PubMed ID: 19773675
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal growth and risk factors for growth deficiency in children treated for acute lymphoblastic leukemia.
Vilela MI; Viana MB
Pediatr Blood Cancer; 2007 Jan; 48(1):86-92. PubMed ID: 16700045
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for early catheter-related infections in cancer patients.
Penel N; Neu JC; Clisant S; Hoppe H; Devos P; Yazdanpanah Y
Cancer; 2007 Oct; 110(7):1586-92. PubMed ID: 17685401
[TBL] [Abstract][Full Text] [Related]
13. Rate, risk factors and outcomes of catheter-related bloodstream infection in a paediatric intensive care unit in Saudi Arabia.
Almuneef MA; Memish ZA; Balkhy HH; Hijazi O; Cunningham G; Francis C
J Hosp Infect; 2006 Feb; 62(2):207-13. PubMed ID: 16307822
[TBL] [Abstract][Full Text] [Related]
14. Impact of reduction of therapy on infectious complications in childhood acute lymphoblastic leukemia.
Graubner UB; Porzig S; Jorch N; Kolb R; Wessalowski R; Escherich G; Janka GE
Pediatr Blood Cancer; 2008 Feb; 50(2):259-63. PubMed ID: 17635005
[TBL] [Abstract][Full Text] [Related]
15. Central venous catheter infections in burn patients with scheduled catheter exchange and replacement.
O'Mara MS; Reed NL; Palmieri TL; Greenhalgh DG
J Surg Res; 2007 Oct; 142(2):341-50. PubMed ID: 17631903
[TBL] [Abstract][Full Text] [Related]
16. How long does it take to "rule out" bacteremia in children with central venous catheters?
Shah SS; Downes KJ; Elliott MR; Bell LM; McGowan KL; Metlay JP
Pediatrics; 2008 Jan; 121(1):135-41. PubMed ID: 18166567
[TBL] [Abstract][Full Text] [Related]
17. Thrombotic effects of asparaginase in two acute lymphoblastic leukemia protocols (NOPHO ALL-1992 versus NOPHO ALL-2000): a single-institution study.
Ruud E; Holmstrøm H; de Lange C; Natvig S; Albertsen BK; Wesenberg F
Pediatr Hematol Oncol; 2006; 23(3):207-16. PubMed ID: 16517537
[TBL] [Abstract][Full Text] [Related]
18. Skin and soft tissue complications in pediatric leukemia patients with and without central venous catheters.
Demircioğlu F; Ylmaz S; Oren H; Ozgüven AA; Irken G
J Pediatr Hematol Oncol; 2008 Jan; 30(1):32-5. PubMed ID: 18176177
[TBL] [Abstract][Full Text] [Related]
19. Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period [corrected].
Magrath I; Shanta V; Advani S; Adde M; Arya LS; Banavali S; Bhargava M; Bhatia K; Gutiérrez M; Liewehr D; Pai S; Sagar TG; Venzon D; Raina V
Eur J Cancer; 2005 Jul; 41(11):1570-83. PubMed ID: 16026693
[TBL] [Abstract][Full Text] [Related]
20. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
Manabe A; Ohara A; Hasegawa D; Koh K; Saito T; Kiyokawa N; Kikuchi A; Takahashi H; Ikuta K; Hayashi Y; Hanada R; Tsuchida M;
Haematologica; 2008 Aug; 93(8):1155-60. PubMed ID: 18519521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
